Latest News

Karolinska Institutet to clinically validate calScreener™ for AST

Published Apr 11, 2018

Internationally renowned clinical microbiologist takes academic lead in Horizon 2020 funded validation of game-changing method for multiple antibiotic resistance evaluation 11 April 2018: Symcel – the company behind the revolutionary

Learn more

Symcel expands staff to promote clinical market growth

Published Feb 7, 2018

L-R: Dr Marta Veses Garcia, Pelle Friberg and Dr Karin Gillner Symcel – producers of the cell-based assay tool for real-time cell metabolism measurements, calScreener — is expanding to bring

Learn more

Symcel Secures €3.6M for Antibiotic Susceptibility Testing

Published Nov 21, 2017

Symcel secures €3.6 million Horizon 2020 Phase II grant for clinical validation of customized antimicrobial susceptibility testing. Multi-resistant bacterial sepsis infections to be validated utilising Symcel’s sensitive screening technology Symcel:

Learn more

Jesper Ericsson appointed new CEO of Symcel

Published Nov 1, 2017

Symcel AB today announces the appointment of Jesper Ericsson as new Chief Executive Officer – succeeding Christer Wallin who is now retiring. 1 September 2017: Symcel has today announced that

Learn more